Tech Company Financing Transactions
Pacira Pharmaceuticals Funding Round
Pacira Pharmaceuticals, operating out of Parsippany, scored $2.4 million from MPM Capital.
Transaction Overview
Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$2,433,000
Round
Undisclosed
Investors
MPM Capital (Luke Evnin)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
5 Sylvan Way
Parsippany, NJ 07054
USA
Parsippany, NJ 07054
USA
Phone
Website
Email Address
Overview
Pacira Pharmaceuticals (Nasdaq: PCRX) has developed DepoFoam, a proprietary sustained-release injectable drug delivery technology to address limitations associated with traditional injectable drug administration.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Stack
Chief Financial Officer
Charles Reinhart
Chief Medical Officer
Richard Scranton
VP - Administration
Kristen Williams
VP - Operations
Charles Laranjeira
Browse more venture capital transactions:
Prev: 3/31/2009: Advanced Hydro venture capital transaction
Next: 3/31/2009: TRF Pharma venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs